Some DNA-binding proteins such as heterogeneous nuclear ribonucleoprotein L (HNRNPL), heterogeneous nuclear ribonucleoprotein U (HNRPU), and interleukin enhancer binding factor 2 (ILF2) are closely associated with endometrial cancer [64]. Here, ILF2 is linked to endometrial cancer.